Cytomx Therapeutics Inc (CTMX)

04:24 AM

CytomX at Barclays Healthcare: Probody Platform Progress - Investing.com

04:24 AM

12:24 PM

CytomX Therapeutics’s SWOT analysis: biotech firm’s stock faces pivotal year - Investing.com India

12:24 PM

Mar 11, 2025

CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Mar 11, 2025

Mar 11, 2025

Are CytomX Therapeutics Inc (CTMX) shares a good deal now? - US Post News

Mar 11, 2025

Mar 11, 2025

CytomX Therapeutics (NASDAQ:CTMX) Upgraded by StockNews.com to “Buy” Rating - Defense World

Mar 11, 2025

Mar 10, 2025

What Are You Thinking About Investing In CytomX Therapeutics Inc (NASDAQ: CTMX) Stock? - Stocks Register

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics’ (CTMX) Outperform Rating Reiterated at Wedbush - Defense World

Mar 10, 2025

Mar 10, 2025

Earnings call transcript: CytomX Therapeutics Q4 2024 reports strong revenue - Investing.com India

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of “Moderate Buy” by Brokerages - Armenian Reporter

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics’ (CTMX) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Mar 10, 2025

Mar 08, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 08, 2025

Mar 08, 2025

CytomX Therapeutics Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 08, 2025

Mar 08, 2025

Analysts Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $5.77 - Defense World

Mar 08, 2025

Mar 08, 2025

CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability - TipRanks

Mar 08, 2025

Mar 07, 2025

CytomX Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

Mar 07, 2025

Mar 07, 2025

CytomX Therapeutics, Inc. (CTMX): Among the Cheap Growth Stocks to Buy Now - Insider Monkey

Mar 07, 2025

Mar 07, 2025

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration - Citeline News & Insights

Mar 07, 2025

Mar 07, 2025

Cautious Outlook for CytomX Therapeutics Amid Pipeline Challenges and Strategic Setbacks - TipRanks

Mar 07, 2025

Mar 07, 2025

CytomX stock plunges to 52-week low, touches $0.6 By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

CytomX Therapeutics Inc earnings beat by $0.43, revenue topped estimates - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada

Mar 07, 2025

Mar 06, 2025

CytomX Therapeutics Reports Strong 2024 Financial Results - TipRanks

Mar 06, 2025

Mar 06, 2025

CytomX To Report Colorectal Cancer Trial Data Of CX-2051 In 1H, 2025 - Nasdaq

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 06, 2025

Mar 06, 2025

Earnings call transcript: CytomX Therapeutics Q4 2024 reports strong revenue By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

CYTOMX THERAPEUTICS Earnings Results: $CTMX Reports Quarterly Earnings - Nasdaq

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics Inc Reports Q4 EPS of $0.38 and Revenue of $138.1 Million, Surpassing Estimates - GuruFocus.com

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update - The Manila Times

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics Advances CX-2051 and CX-801 Programs, Reports Strengthened Financial Position - Nasdaq

Mar 06, 2025

Mar 06, 2025

CytomX stock plunges to 52-week low, touches $0.6 - Investing.com India

Mar 06, 2025

Mar 06, 2025

Daily Progress: CytomX Therapeutics Inc (CTMX) Drop -5.76, Closing at 0.62 - The Dwinnex

Mar 06, 2025

Mar 06, 2025

10 Cheap Growth Stocks to Buy Now - Insider Monkey

Mar 06, 2025

Mar 06, 2025

CytomX Therapeutics, Inc. to Host Earnings Call - accessnewswire.com

Mar 06, 2025

Mar 05, 2025

CytomX Gears Up to Report Q4 Earnings: What Should Investors Expect? - MSN

Mar 05, 2025

Mar 05, 2025

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference - The Manila Times

Mar 05, 2025

Mar 05, 2025

Can CytomX's Conference Presentation Reveal New Strategic Directions for Its Masked Biologics Platform? - StockTitan

Mar 05, 2025

Mar 05, 2025

Earnings To Watch: CytomX Therapeutics Inc (CTMX) Reports Q4 202 - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Earnings To Watch: CytomX Therapeutics Inc (CTMX) Reports Q4 2024 Result - Yahoo Finance

Mar 05, 2025

Mar 04, 2025

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Mar 04, 2025

Mar 01, 2025

CytomX Therapeutics (CTMX) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 01, 2025

Feb 28, 2025

CytomX Therapeutics (NASDAQ:CTMX) Stock Crosses Below Fifty Day Moving AverageShould You Sell? - MarketBeat

Feb 28, 2025

Feb 27, 2025

CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - The Manila Times

Feb 27, 2025

Feb 27, 2025

When Will CytomX Release Q4 2024 Results? Key Date for Biotech Investors - StockTitan

Feb 27, 2025

Feb 27, 2025

CytomX faces Nasdaq delisting over share price woes - Investing.com India

Feb 27, 2025

Feb 26, 2025

CytomX faces Nasdaq delisting over share price woes By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 24, 2025

CytomX stock hits 52-week low at $0.74 amid market challenges - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

CytomX stock hits 52-week low at $0.74 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025